The expression of ELOVL4 was three times higher in CRC patients than in normal tissue, whereas in cell models, it was three times higher in HT-29 and approximately six times higher in WiDr in comparison to normal colon cells. This evidence concerns the gene ELOVL4 and colorectal carcinoma.